close
Current Approaches for the Preclinical Development of Novel Biologics, Biosimilars and Specialty Biologics | Zookal Textbooks | Zookal Textbooks
  • Author(s) Danuta Herzyk / Lisa Plitnick
  • Edition1
  • Published19th July 2013
  • PublisherAcademic Press
  • ISBN9780123948106
Nonclinical Development of Novel Biologics, Biosimilars, Vaccines and Specialty Biologics is a complete reference devoted to the nonclinical safety assessment of novel biopharmaceuticals, biosimilars, vaccines, cell and gene therapies and blood products. This book compares and contrasts these types of biologics with one another and with small molecule drugs, while incorporating the most current and essential international regulatory documents. Each section discusses a different type of biologic, as well as early characterization strategies, principles of study design, preclinical pharmacokinetics and pharmacodynamics and preclinical assays. An edited book that is authored by leading experts in the field, this comprehensive reference provides critical insights to all researchers involved in early through late stage biologics.

Current Approaches for the Preclinical Development of Novel Biologics, Biosimilars and Specialty Biologics

Print on Demand

Leaves 13-18 days after printing

$199.76 $206.95 Save $7.19
Add Zookal Study FREE trial and save a further 10% 

NEW PRICE

$179.78 + free shipping

(10% off - save $19.98)

Zookal Study Free trial

14-day FREE trial. $14.95/mo after. Cancel anytime.

*Discount will apply at checkout.

 See terms and conditions

You will get a further 10% off for this item ($179.78 after discount) because you have added Zookal Study Premium Free Trial to your bag.

For this discount to apply, you will need to complete checkout with the Zookal Study Premium Free Trial in your bag.

-
+
Get it instantly

Zookal account needed

$200.95
Add Zookal Study FREE trial and save a further 10% 

NEW PRICE

$180.86 + free shipping

(10% off - save $20.10)

Zookal Study Free trial

14-day FREE trial. $14.95/mo after. Cancel anytime.

*Discount will apply at checkout.

 See terms and conditions

You will get a further 10% off for this item ($180.86 after discount) because you have added Zookal Study Premium Free Trial to your bag.

For this discount to apply, you will need to complete checkout with the Zookal Study Premium Free Trial in your bag.

-
+
  • Author(s) Danuta Herzyk / Lisa Plitnick
  • Edition1
  • Published19th July 2013
  • PublisherAcademic Press
  • ISBN9780123948106
Nonclinical Development of Novel Biologics, Biosimilars, Vaccines and Specialty Biologics is a complete reference devoted to the nonclinical safety assessment of novel biopharmaceuticals, biosimilars, vaccines, cell and gene therapies and blood products. This book compares and contrasts these types of biologics with one another and with small molecule drugs, while incorporating the most current and essential international regulatory documents. Each section discusses a different type of biologic, as well as early characterization strategies, principles of study design, preclinical pharmacokinetics and pharmacodynamics and preclinical assays. An edited book that is authored by leading experts in the field, this comprehensive reference provides critical insights to all researchers involved in early through late stage biologics.
translation missing: en.general.search.loading